{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:46:26Z","timestamp":1794293186029,"version":"4.9.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008130","name":"Pusan National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014578","name":"National Institute for Health and Welfare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014578","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>We present a review of research on the role of melatonin in the management of sleep and circadian disorders, stressing current overall view of the knowledge across psychiatric disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Dysregulation of sleep and circadian rhythms has been established in several psychiatric and neurocognitive disorders for long. Recent research confirms this finding consistently across disorders. The secretion of melatonin in schizophrenia and neurocognitive disorders is reduced due to a smaller volume and enlarged calcification of the pineal gland. On the other hand, melatonin dysregulation in bipolar disorder may be more dynamic and caused by light-sensitive melatonin suppression and delayed melatonin secretion. In both cases, exogenous melatonin seems indicated to correct the dysfunction. However, a very limited number of well-designed trials with melatonin to correct sleep and circadian rhythms exist in psychiatric disorders, and the evidence for efficacy is robust only in autism, attention deficit hyperactivity disorder (ADHD), and neurocognitive disorders. This topic has mainly not been of interest for recent work and well-designed trials with objective circadian parameters are few. Overall, recent studies in psychiatric disorders reported that melatonin can be effective in improving sleep parameters such as sleep onset latency, sleep efficiency, and sleep quality. Recent meta-analysis suggests that optimal dosage and dosing time might be important to maximize the efficacy of melatonin. The knowledge base is sufficient to propose well-designed, larger trials with circadian parameters as inclusion and outcome criteria. Based on the partly fragmentary information, we propose testing efficacy in disorders with neurocognitive etiopathology with later and higher dosing, and affective and anxiety disorders with lower and earlier dosing of melatonin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Melatonin is promising for the correction of sleep and circadian abnormalities in psychiatric disorders. However, research results on its effect are still few and need to be accumulated. For effective use of melatonin, it is necessary to consider the appropriate dosage and administration time, depending on the individual abnormality of sleep and circadian rhythms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11920-022-01369-6","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T11:03:18Z","timestamp":1665658998000},"page":"623-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness"],"prefix":"10.1007","volume":"24","author":[{"given":"Eunsoo","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Partonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-7215","authenticated-orcid":false,"given":"Outi","family":"Linnaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"issue":"1","key":"1369_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13073-019-0704-0","volume":"11","author":"F Rijo-Ferreira","year":"2019","unstructured":"Rijo-Ferreira F, Takahashi JS. Genomics of circadian rhythms in health and disease. Genome Med. 2019;11(1):82. https:\/\/doi.org\/10.1186\/s13073-019-0704-0.","journal-title":"Genome Med"},{"key":"1369_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaa024","author":"N Meyer","year":"2020","unstructured":"Meyer N, Faulkner SM, McCutcheon RA, Pillinger T, Dijk DJ, MacCabe JH. Sleep and circadian rhythm disturbance in remitted schizophrenia and bipolar disorder: a systematic review and meta-analysis. Schizophr Bull. 2020. https:\/\/doi.org\/10.1093\/schbul\/sbaa024.","journal-title":"Schizophr Bull"},{"issue":"1","key":"1369_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41398-020-0694-0","volume":"10","author":"WH Walker II","year":"2020","unstructured":"\u2022 Walker WH II, Walton JC, DeVries AC, Nelson RJ. Circadian rhythm disruption and mental health. Transl Psychiatry. 2020;10(1):28. https:\/\/doi.org\/10.1038\/s41398-020-0694-0. This review paper integrated the relevance of circadian rhythm disruption and mental health. Also, this paper explained the importance of correcting circadian rhythm disruptions with results of clinical and animal studies.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"1369_CR4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1176\/appi.ajp.2008.07121882","volume":"165","author":"HJ Cho","year":"2008","unstructured":"Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry. 2008;165(12):1543\u201350. https:\/\/doi.org\/10.1176\/appi.ajp.2008.07121882.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1369_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.9758\/cpn.2021.19.1.125","volume":"19","author":"R Maiti","year":"2021","unstructured":"Maiti R, Mishra BR, Jena M, Mishra A, Nath S. Effect of haloperidol and risperidone on serum melatonin and GAP-43 in patients with schizophrenia: a prospective cohort study. Clin Psychopharmacol Neurosci. 2021;19(1):125\u201334. https:\/\/doi.org\/10.9758\/cpn.2021.19.1.125.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"4","key":"1369_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","volume":"15","author":"C Cajochen","year":"2003","unstructured":"Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol. 2003;15(4):432\u20137. https:\/\/doi.org\/10.1046\/j.1365-2826.2003.00989.x.","journal-title":"J Neuroendocrinol"},{"key":"1369_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.666541","volume":"12","author":"M Dmitrzak-Weglarz","year":"2021","unstructured":"Dmitrzak-Weglarz M, Banach E, Bilska K, Narozna B, Szczepankiewicz A, Reszka E, et al. Molecular regulation of the melatonin biosynthesis pathway in unipolar and bipolar depression. Front Pharmacol. 2021;12: 666541. https:\/\/doi.org\/10.3389\/fphar.2021.666541.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1369_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/revneuro-2021-0022","volume":"33","author":"F Abdul","year":"2022","unstructured":"Abdul F, Sreenivas N, Kommu JVS, Banerjee M, Berk M, Maes M, et al. Disruption of circadian rhythm and risk of autism spectrum disorder: role of immune-inflammatory, oxidative stress, metabolic and neurotransmitter pathways. Rev Neurosci. 2022;33(1):93\u2013109. https:\/\/doi.org\/10.1515\/revneuro-2021-0022.","journal-title":"Rev Neurosci"},{"issue":"1","key":"1369_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-019-0330-8","volume":"14","author":"J Song","year":"2019","unstructured":"Song J. Pineal gland dysfunction in Alzheimer\u2019s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis. Mol Neurodegener. 2019;14(1):28. https:\/\/doi.org\/10.1186\/s13024-019-0330-8.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1369_CR10","first-page":"41","volume":"17","author":"JH Lee","year":"2019","unstructured":"Lee JH, Moon E. Changes of the melatonergic system in bipolar disorder: a literature review. Mood and Emotion. 2019;17(2):41\u20138.","journal-title":"Mood and Emotion"},{"issue":"1","key":"1369_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00415-020-10381-w","volume":"269","author":"G Fatemeh","year":"2022","unstructured":"Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022;269(1):205\u201316. https:\/\/doi.org\/10.1007\/s00415-020-10381-w.","journal-title":"J Neurol"},{"key":"1369_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","volume":"56","author":"J Liu","year":"2016","unstructured":"Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol. 2016;56:361\u201383. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010814-124742.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1369_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fendo.2019.00087","volume":"10","author":"G Gobbi","year":"2019","unstructured":"Gobbi G, Comai S. Differential function of melatonin MT1 and MT2 receptors in REM and NREM sleep. Front Endocrinol (Lausanne). 2019;10:87. https:\/\/doi.org\/10.3389\/fendo.2019.00087.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"20","key":"1369_CR14","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.2174\/0929867329666220105115755","volume":"29","author":"M Pohanka","year":"2022","unstructured":"Pohanka M. New uses of melatonin as a drug; a review. Curr Med Chem. 2022;29(20):3622\u201337. https:\/\/doi.org\/10.2174\/0929867329666220105115755.","journal-title":"Curr Med Chem"},{"key":"1369_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","volume":"34","author":"F Auld","year":"2017","unstructured":"Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. 2017;34:10\u201322. https:\/\/doi.org\/10.1016\/j.smrv.2016.06.005.","journal-title":"Sleep Med Rev"},{"key":"1369_CR16","doi-asserted-by":"publisher","first-page":"107994","DOI":"10.1016\/j.drugalcdep.2020.107994","volume":"212","author":"AL Morera-Fumero","year":"2020","unstructured":"Morera-Fumero AL, Fernandez-Lopez L, Abreu-Gonzalez P. Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review Drug Alcohol Depend. 2020;212:107994. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107994.","journal-title":"A systematic review Drug Alcohol Depend"},{"key":"1369_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.sleep.2020.10.018","volume":"76","author":"H Xu","year":"2020","unstructured":"Xu H, Zhang C, Qian Y, Zou J, Li X, Liu Y, et al. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. Sleep Med. 2020;76:113\u20139. https:\/\/doi.org\/10.1016\/j.sleep.2020.10.018.","journal-title":"Sleep Med"},{"issue":"10","key":"1369_CR18","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1210\/jc.86.10.4727","volume":"86","author":"IV Zhdanova","year":"2001","unstructured":"Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727\u201330. https:\/\/doi.org\/10.1210\/jc.86.10.4727.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1369_CR19","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/sleep\/33.12.1605","volume":"33","author":"IM van Geijlswijk","year":"2010","unstructured":"van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33(12):1605\u201314. https:\/\/doi.org\/10.1093\/sleep\/33.12.1605.","journal-title":"Sleep"},{"issue":"6","key":"1369_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002587","volume":"15","author":"TL Sletten","year":"2018","unstructured":"Sletten TL, Magee M, Murray JM, Gordon CJ, Lovato N, Kennaway DJ, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med. 2018;15(6):1\u201324. https:\/\/doi.org\/10.1371\/journal.pmed.1002587.","journal-title":"PLoS Med"},{"issue":"6","key":"1369_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3109\/07420529808993201","volume":"15","author":"A Suhner","year":"1998","unstructured":"Suhner A, Schlagenhauf P, Johnson R, Tschopp A, Steffen R. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiol Int. 1998;15(6):655\u201366. https:\/\/doi.org\/10.3109\/07420529808993201.","journal-title":"Chronobiol Int"},{"issue":"9","key":"1369_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1176\/ajp.156.9.1392","volume":"156","author":"RL Spitzer","year":"1999","unstructured":"Spitzer RL, Terman M, Williams JBW, Terman JS, Malt UF, Singer F, et al. Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial. Am J Psychiatry. 1999;156(9):1392\u20136.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1369_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1365-2869.2001.00256.x","volume":"10","author":"KM Sharkey","year":"2001","unstructured":"Sharkey KM, Fogg LF, Eastman CI. Effects of melatonin administration on daytime sleep after simulated night shift work. J Sleep Res. 2001;10(3):181\u201392. https:\/\/doi.org\/10.1046\/j.1365-2869.2001.00256.x.","journal-title":"J Sleep Res"},{"issue":"1","key":"1369_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3233\/wor-162376","volume":"55","author":"K Sadeghniiat-Haghighi","year":"2016","unstructured":"Sadeghniiat-Haghighi K, Bahrami H, Aminian O, Meysami A, Khajeh-Mehrizi A. Melatonin therapy in shift workers with difficulty falling asleep: a randomized, double-blind, placebo-controlled crossover field study. Work. 2016;55(1):225\u201330. https:\/\/doi.org\/10.3233\/wor-162376.","journal-title":"Work"},{"issue":"1","key":"1369_CR25","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.0.164r001","volume":"164","author":"SW Lockley","year":"2000","unstructured":"Lockley SW, Skene DJ, James K, Thapan K, Wright J, Arendt J. Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol. 2000;164(1):R1-6. https:\/\/doi.org\/10.1677\/joe.0.164r001.","journal-title":"J Endocrinol"},{"issue":"15","key":"1369_CR26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1056\/NEJM200010123431503","volume":"343","author":"RL Sack","year":"2000","unstructured":"Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med. 2000;343(15):1070\u20137. https:\/\/doi.org\/10.1056\/NEJM200010123431503.","journal-title":"N Engl J Med"},{"key":"1369_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fpsyt.2019.00366","volume":"10","author":"C Carmassi","year":"2019","unstructured":"Carmassi C, Palagini L, Caruso D, Masci I, Nobili L, Vita A, et al. Systematic review of sleep disturbances and circadian sleep desynchronization in autism spectrum disorder: toward an integrative model of a self-reinforcing loop. Front Psychiatry. 2019;10:366. https:\/\/doi.org\/10.3389\/fpsyt.2019.00366.","journal-title":"Front Psychiatry"},{"key":"1369_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10040219","author":"B Rzepka-Migut","year":"2020","unstructured":"Rzepka-Migut B, Paprocka J. Efficacy and safety of melatonin treatment in children with autism spectrum disorder and attention-deficit\/hyperactivity disorder-a review of the literature. Brain Sci. 2020. https:\/\/doi.org\/10.3390\/brainsci10040219.","journal-title":"Brain Sci"},{"key":"1369_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2021.09.009","volume":"126","author":"E Martinez-Cayuelas","year":"2022","unstructured":"Martinez-Cayuelas E, Rodriguez-Morilla B, Soriano-Guillen L, Merino-Andreu M, Moreno-Vinues B, Gavela-Perez T. Sleep problems and circadian functioning in children and adolescents with autism spectrum disorder. Pediatr Neurol. 2022;126:57\u201364. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.09.009.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1369_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5080\/u25160","volume":"31","author":"AS Yenen","year":"2020","unstructured":"Yenen AS, Cak HT. Melatonin and circadian rhythm in autism spectrum disorders. Turk Psikiyatri Derg. 2020;31(3):201\u201311. https:\/\/doi.org\/10.5080\/u25160.","journal-title":"Turk Psikiyatri Derg"},{"key":"1369_CR31","doi-asserted-by":"publisher","first-page":"642745","DOI":"10.3389\/fnins.2021.642745","volume":"15","author":"E Lorsung","year":"2021","unstructured":"\u2022 Lorsung E, Karthikeyan R, Cao R. Biological timing and neurodevelopmental disorders: a role for circadian dysfunction in autism spectrum disorders. Front Neurosci. 2021;15:642745. https:\/\/doi.org\/10.3389\/fnins.2021.642745. This paper systematically reviewed studies on biological timing and neurodevelopmental disorders, especially in autism spectrum disorders. This review suggests on the optimal usage of melatonin supplements in neurodevelopmental disorder like autism.","journal-title":"Front Neurosci"},{"issue":"18","key":"1369_CR32","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1080\/14656566.2021.1959549","volume":"22","author":"CM Schroder","year":"2021","unstructured":"Schroder CM, Banaschewski T, Fuentes J, Hill CM, Hvolby A, Posserud MB, et al. Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders. Expert Opin Pharmacother. 2021;22(18):2445\u201354. https:\/\/doi.org\/10.1080\/14656566.2021.1959549.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"1369_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaac.2019.12.007","volume":"60","author":"BA Malow","year":"2021","unstructured":"Malow BA, Findling RL, Schroder CM, Maras A, Breddy J, Nir T, et al. Sleep, growth, and puberty after 2 years of prolonged-release melatonin in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2021;60(2):252-61.e3. https:\/\/doi.org\/10.1016\/j.jaac.2019.12.007.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"1369_CR34","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1007\/s10803-021-05139-w","volume":"52","author":"M Hayashi","year":"2022","unstructured":"Hayashi M, Mishima K, Fukumizu M, Takahashi H, Ishikawa Y, Hamada I, et al. Melatonin treatment and adequate sleep hygiene interventions in children with autism spectrum disorder: a randomized controlled trial. J Autism Dev Disord. 2022;52(6):2784\u201393. https:\/\/doi.org\/10.1007\/s10803-021-05139-w.","journal-title":"J Autism Dev Disord"},{"key":"1369_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2022.02.005","author":"E Martinez-Cayuelas","year":"2022","unstructured":"Martinez-Cayuelas E, Moreno-Vinues B, Pozo RL, Rodrigo-Moreno M, Soto-Insuga V, Perez-Villena A. Sleep, chronotype, and behavior in adolescents with attention-deficit\/hyperactivity disorder. Arch Pediatr. 2022. https:\/\/doi.org\/10.1016\/j.arcped.2022.02.005.","journal-title":"Arch Pediatr"},{"issue":"2","key":"1369_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1087054720978556","volume":"26","author":"U Bondopadhyay","year":"2022","unstructured":"Bondopadhyay U, Diaz-Orueta U, Coogan AN. A systematic review of sleep and circadian rhythms in children with attention deficit hyperactivity disorder. J Atten Disord. 2022;26(2):149\u2013224. https:\/\/doi.org\/10.1177\/1087054720978556.","journal-title":"J Atten Disord"},{"key":"1369_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pnpbp.2016.01.006","volume":"67","author":"AN Coogan","year":"2016","unstructured":"Coogan AN, Baird AL, Popa-Wagner A, Thome J. Circadian rhythms and attention deficit hyperactivity disorder: the what, the when and the why. Prog Neuropsychopharmacol Biol Psychiatry. 2016;67:74\u201381. https:\/\/doi.org\/10.1016\/j.pnpbp.2016.01.006.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1369_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2018.05.002","volume":"103","author":"L Tonetti","year":"2018","unstructured":"Tonetti L, Conca A, Giupponi G, Filardi M, Natale V. Circadian activity rhythm in adult attention-deficit hyperactivity disorder. J Psychiatr Res. 2018;103:1\u20134. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.05.002.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"1369_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5664\/jcsm.27356","volume":"4","author":"AS Walters","year":"2008","unstructured":"Walters AS, Silvestri R, Zucconi M, Chandrashekariah R, Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med. 2008;4(6):591\u2013600.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"1369_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/07420528.2020.1835943","volume":"38","author":"E van Andel","year":"2021","unstructured":"van Andel E, Bijlenga D, Vogel SWN, Beekman ATF, Kooij JJS. Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit\/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial. Chronobiol Int. 2021;38(2):260\u20139. https:\/\/doi.org\/10.1080\/07420528.2020.1835943.","journal-title":"Chronobiol Int"},{"issue":"11","key":"1369_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/pcn.13103","volume":"74","author":"T Matsuoka","year":"2020","unstructured":"Matsuoka T, Oya N, Yokota H, Akazawa K, Yamada K, Narumoto J, et al. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer\u2019s disease. Psychiatry Clin Neurosci. 2020;74(11):587\u201393. https:\/\/doi.org\/10.1111\/pcn.13103.","journal-title":"Psychiatry Clin Neurosci"},{"key":"1369_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fendo.2019.00480","volume":"10","author":"DP Cardinali","year":"2019","unstructured":"\u2022 Cardinali DP. Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne). 2019;10:480. https:\/\/doi.org\/10.3389\/fendo.2019.00480. This paper reviewed the clinical perspectives of melatonin supplements in neurodegenerative disorders. This review paper comprehensively summarized the results of melatonin supplements in clinical trials and animal studies.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1369_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080672","author":"N Sadanandan","year":"2020","unstructured":"Sadanandan N, Cozene B, Cho J, Park YJ, Saft M, Gonzales-Portillo B, et al. Melatonin-a potent therapeutic for stroke and stroke-related dementia. Antioxidants (Basel). 2020. https:\/\/doi.org\/10.3390\/antiox9080672.","journal-title":"Antioxidants (Basel)."},{"key":"1369_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.schres.2018.11.032","volume":"206","author":"T Takahashi","year":"2019","unstructured":"Takahashi T, Nakamura M, Sasabayashi D, Nishikawa Y, Takayanagi Y, Nishiyama S, et al. Reduced pineal gland volume across the stages of schizophrenia. Schizophr Res. 2019;206:163\u201370. https:\/\/doi.org\/10.1016\/j.schres.2018.11.032.","journal-title":"Schizophr Res"},{"key":"1369_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.psyneuen.2019.02.024","volume":"104","author":"MAV Bastos Jr","year":"2019","unstructured":"Bastos MAV Jr, Oliveira Bastos PRH, Portella RB, Soares LFG, Conde RB, Rodrigues PMF Jr, et al. Pineal gland and schizophrenia: a systematic review and meta-analysis. Psychoneuroendocrinology. 2019;104:100\u201314. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.02.024.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"1369_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1192\/bjp.bp.111.096321","volume":"200","author":"K Wulff","year":"2012","unstructured":"Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry. 2012;200(4):308\u201316. https:\/\/doi.org\/10.1192\/bjp.bp.111.096321.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1369_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4088\/JCP.v61n0509","volume":"61","author":"E Shamir","year":"2000","unstructured":"Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry. 2000;61(5):373\u20137. https:\/\/doi.org\/10.4088\/JCP.v61n0509.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1369_CR48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/00004714-200012000-00017","volume":"20","author":"E Shamir","year":"2000","unstructured":"Shamir E, Rotenberg VS, Laudon M, Zisapel N, Elizur A. First-night effect of melatonin treatment in patients with chronic schizophrenia. J Clin Psychopharmacol. 2000;20(6):691\u20134. https:\/\/doi.org\/10.1097\/00004714-200012000-00017.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"1369_CR49","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5498\/wjp.v11.i8.463","volume":"11","author":"C Duan","year":"2021","unstructured":"Duan C, Jenkins ZM, Castle D. Therapeutic use of melatonin in schizophrenia: a systematic review. World J Psychiatry. 2021;11(8):463\u201376. https:\/\/doi.org\/10.5498\/wjp.v11.i8.463.","journal-title":"World J Psychiatry"},{"key":"1369_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.smrv.2016.06.007","volume":"34","author":"MCA Melo","year":"2017","unstructured":"Melo MCA, Abreu RLC, Linhares Neto VB, de Bruin PFC, de Bruin VMS. Chronotype and circadian rhythm in bipolar disorder: a systematic review. Sleep Med Rev. 2017;34:46\u201358. https:\/\/doi.org\/10.1016\/j.smrv.2016.06.007.","journal-title":"Sleep Med Rev"},{"key":"1369_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpsychires.2016.09.005","volume":"83","author":"MC Melo","year":"2016","unstructured":"Melo MC, Garcia RF, Linhares Neto VB, Sa MB, de Mesquita LM, de Araujo CF, et al. Sleep and circadian alterations in people at risk for bipolar disorder: a systematic review. J Psychiatr Res. 2016;83:211\u20139. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.09.005.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"1369_CR52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s40263-019-00673-9","volume":"33","author":"A Porcu","year":"2019","unstructured":"Porcu A, Gonzalez R, McCarthy MJ. Pharmacological manipulation of the circadian clock: a possible approach to the management of bipolar disorder. CNS Drugs. 2019;33(10):981\u201399. https:\/\/doi.org\/10.1007\/s40263-019-00673-9.","journal-title":"CNS Drugs"},{"key":"1369_CR53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ebiom.2016.08.019","volume":"11","author":"JH Moon","year":"2016","unstructured":"Moon JH, Cho CH, Son GH, Geum D, Chung S, Kim H, et al. advanced circadian phase in mania and delayed circadian phase in mixed mania and depression returned to normal after treatment of bipolar disorder. EBioMedicine. 2016;11:285\u201395. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.019.","journal-title":"EBioMedicine"},{"key":"1369_CR54","doi-asserted-by":"publisher","unstructured":"Tian E, Bourguignon C, Beaulieu S, Storch KF, Linnaranta O A possible shared dysregulation of sleep and eating in bipolar disorders? J Behav Cogn Ther 2021;31(4):337\u2013347, ISSN 2589-9791. https:\/\/doi.org\/10.1016\/j.jbct.2021.08.001.","DOI":"10.1016\/j.jbct.2021.08.001"},{"issue":"23","key":"1369_CR55","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.2174\/1381612821666150619093448","volume":"21","author":"PA Geoffroy","year":"2015","unstructured":"Geoffroy PA, Etain B, Franchi JA, Bellivier F, Ritter P. Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders. Curr Pharm Des. 2015;21(23):3352\u20138. https:\/\/doi.org\/10.2174\/1381612821666150619093448.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1369_CR56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/YIC.0b013e32832c260b","volume":"25","author":"MA Serfaty","year":"2010","unstructured":"Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. Int Clin Psychopharmacol. 2010;25(3):132\u201342. https:\/\/doi.org\/10.1097\/YIC.0b013e32832c260b.","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"1369_CR57","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.pnpbp.2010.07.028","volume":"35","author":"P Monteleone","year":"2011","unstructured":"Monteleone P, Martiadis V, Maj M. Circadian rhythms and treatment implications in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1569\u201374. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.07.028.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"1369_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0163-7258(96)00092-7","volume":"71","author":"WC Duncan Jr","year":"1996","unstructured":"Duncan WC Jr. Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther. 1996;71(3):253\u2013312. https:\/\/doi.org\/10.1016\/s0163-7258(96)00092-7.","journal-title":"Pharmacol Ther"},{"issue":"5 Suppl","key":"1369_CR59","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/S0893-133X(01)00340-2","volume":"25","author":"BL Parry","year":"2001","unstructured":"Parry BL, Newton RP. Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology. 2001;25(5 Suppl):S102\u20138. https:\/\/doi.org\/10.1016\/S0893-133X(01)00340-2.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1369_CR60","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1038\/s41598-021-91205-3","volume":"11","author":"R Norbury","year":"2021","unstructured":"Norbury R. Diurnal preference and depressive symptomatology: a meta-analysis. Sci Rep. 2021;11(1):12003. https:\/\/doi.org\/10.1038\/s41598-021-91205-3.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"1369_CR61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/15622975.2011.598389","volume":"12","author":"AN Coogan","year":"2011","unstructured":"Coogan AN, Thome J. Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms. World J Biol Psychiatry. 2011;12(Suppl 1):40\u20133. https:\/\/doi.org\/10.3109\/15622975.2011.598389.","journal-title":"World J Biol Psychiatry"},{"key":"1369_CR62","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jad.2021.05.080","volume":"292","author":"L Bertrand","year":"2021","unstructured":"Bertrand L, d\u2019Ortho MP, Reynaud E, Lejoyeux M, Bourgin P, Geoffroy PA. Polysomnography in seasonal affective disorder: a systematic review and meta-analysis. J Affect Disord. 2021;292:405\u201315. https:\/\/doi.org\/10.1016\/j.jad.2021.05.080.","journal-title":"J Affect Disord"},{"issue":"8","key":"1369_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1176\/ajp.155.8.1119","volume":"155","author":"OT Dolberg","year":"1998","unstructured":"Dolberg OT, Hirschmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry. 1998;155(8):1119\u201321. https:\/\/doi.org\/10.1176\/ajp.155.8.1119.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"1369_CR64","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.euroneuro.2014.08.008","volume":"24","author":"MV Hansen","year":"2014","unstructured":"Hansen MV, Danielsen AK, Hageman I, Rosenberg J, Gogenur I. The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24(11):1719\u201328. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.08.008.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1369_CR65","doi-asserted-by":"publisher","first-page":"100931","DOI":"10.1016\/j.yfrne.2021.100931","volume":"63","author":"SM Ota","year":"2021","unstructured":"Ota SM, Kong X, Hut R, Suchecki D, Meerlo P. The impact of stress and stress hormones on endogenous clocks and circadian rhythms. Front Neuroendocrinol. 2021;63:100931. https:\/\/doi.org\/10.1016\/j.yfrne.2021.100931.","journal-title":"Front Neuroendocrinol"},{"key":"1369_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ynstr.2016.09.001","volume":"6","author":"CE Koch","year":"2017","unstructured":"Koch CE, Leinweber B, Drengberg BC, Blaum C, Oster H. Interaction between circadian rhythms and stress. Neurobiol Stress. 2017;6:57\u201367. https:\/\/doi.org\/10.1016\/j.ynstr.2016.09.001.","journal-title":"Neurobiol Stress"},{"issue":"9","key":"1369_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11920-015-0613-x","volume":"17","author":"ME Coles","year":"2015","unstructured":"Coles ME, Schubert JR, Nota JA. Sleep, Circadian rhythms, and anxious traits. Curr Psychiatry Rep. 2015;17(9):73. https:\/\/doi.org\/10.1007\/s11920-015-0613-x.","journal-title":"Curr Psychiatry Rep"},{"key":"1369_CR68","doi-asserted-by":"publisher","first-page":"104514","DOI":"10.1016\/j.psyneuen.2019.104514","volume":"112","author":"I Sundberg","year":"2020","unstructured":"Sundberg I, Rasmusson AJ, Ramklint M, Just D, Ekselius L, Cunningham JL. Daytime melatonin levels in saliva are associated with inflammatory markers and anxiety disorders. Psychoneuroendocrinology. 2020;112:104514. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104514.","journal-title":"Psychoneuroendocrinology"},{"key":"1369_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/abr.abr_106_19","volume":"8","author":"R Abbasivash","year":"2019","unstructured":"Abbasivash R, Salimi S, Ahsan B, Moallemi N, Sane S. The effect of melatonin on anxiety and pain of tourniquet in intravenous regional anesthesia. Adv Biomed Res. 2019;8:67. https:\/\/doi.org\/10.4103\/abr.abr_106_19.","journal-title":"Adv Biomed Res"},{"key":"1369_CR70","doi-asserted-by":"publisher","first-page":"CD009861","DOI":"10.1002\/14651858.CD009861.pub3","volume":"12","author":"BK Madsen","year":"2020","unstructured":"Madsen BK, Zetner D, Moller AM, Rosenberg J. Melatonin for preoperative and postoperative anxiety in adults. Cochrane Database Syst Rev. 2020;12:CD009861. https:\/\/doi.org\/10.1002\/14651858.CD009861.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1369_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.32598\/bcn.12.1.1650.2","volume":"12","author":"M Shahrokhi","year":"2021","unstructured":"Shahrokhi M, Ghaeli P, Arya P, Shakiba A, Noormandi A, Soleimani M, et al. Comparing the effects of melatonin and zolpidem on sleep quality, depression, and anxiety in patients with colorectal cancer undergoing chemotherapy. Basic Clin Neurosci. 2021;12(1):105\u201314. https:\/\/doi.org\/10.32598\/bcn.12.1.1650.2.","journal-title":"Basic Clin Neurosci"},{"issue":"1","key":"1369_CR72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0748730408328914","volume":"24","author":"N Goel","year":"2009","unstructured":"Goel N, Stunkard AJ, Rogers NL, Van Dongen HP, Allison KC, O\u2019Reardon JP, et al. Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms. 2009;24(1):85\u201394. https:\/\/doi.org\/10.1177\/0748730408328914.","journal-title":"J Biol Rhythms"},{"issue":"2","key":"1369_CR73","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/07420528.2017.1392549","volume":"35","author":"E Roveda","year":"2018","unstructured":"Roveda E, Montaruli A, Galasso L, Pesenti C, Bruno E, Pasanisi P, et al. Rest-activity circadian rhythm and sleep quality in patients with binge eating disorder. Chronobiol Int. 2018;35(2):198\u2013207. https:\/\/doi.org\/10.1080\/07420528.2017.1392549.","journal-title":"Chronobiol Int"},{"key":"1369_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kaaa012","author":"O Linnaranta","year":"2020","unstructured":"Linnaranta O, Bourguignon C, Crescenzi O, Sibthorpe D, Buyukkurt A, Steiger H, et al. Late and instable sleep phasing is associated with irregular eating patterns in eating disorders. Ann Behav Med. 2020. https:\/\/doi.org\/10.1093\/abm\/kaaa012.","journal-title":"Ann Behav Med"},{"key":"1369_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.sleep.2018.03.032","volume":"48","author":"TA Abdou","year":"2018","unstructured":"Abdou TA, Esawy HI, Mohamed GAR, Ahmed HH, Elhabiby MM, Khalil SA, et al. Sleep profile in anorexia and bulimia nervosa female patients. Sleep Med. 2018;48:113\u20136. https:\/\/doi.org\/10.1016\/j.sleep.2018.03.032.","journal-title":"Sleep Med"},{"key":"1369_CR76","unstructured":"ClinicalTrials.gov(NCT02500017). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02500017 .2018. Accessed 4 Jul 2022."},{"issue":"11","key":"1369_CR77","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaac.2017.09.414","volume":"56","author":"P Gringras","year":"2017","unstructured":"Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL. Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2017;56(11):948-57.e4. https:\/\/doi.org\/10.1016\/j.jaac.2017.09.414.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"1369_CR78","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/cap.2018.0020","volume":"28","author":"A Maras","year":"2018","unstructured":"Maras A, Schroder CM, Malow BA, Findling RL, Breddy J, Nir T, et al. Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2018;28(10):699\u2013710. https:\/\/doi.org\/10.1089\/cap.2018.0020.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"1369_CR79","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s40263-019-00680-w","volume":"33","author":"FMC Besag","year":"2019","unstructured":"Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs. 2019;33(12):1167\u201386. https:\/\/doi.org\/10.1007\/s40263-019-00680-w.","journal-title":"CNS Drugs"},{"issue":"2","key":"1369_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4140\/TCP.n.2021.83","volume":"36","author":"SM Almond","year":"2021","unstructured":"Almond SM, Warren MJ, Shealy KM, Threatt TB, Ward ED. A systematic review of the efficacy and safety of over-the-counter medications used in older people for the treatment of primary insomnia. Sr Care Pharm. 2021;36(2):83\u201392. https:\/\/doi.org\/10.4140\/TCP.n.2021.83.","journal-title":"Sr Care Pharm"},{"issue":"2","key":"1369_CR81","doi-asserted-by":"publisher","first-page":"e12782","DOI":"10.1111\/jpi.12782","volume":"72","author":"Z Menczel Schrire","year":"2022","unstructured":"Menczel Schrire Z, Phillips CL, Chapman JL, Duffy SL, Wong G, D\u2019Rozario AL, et al. Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. J Pineal Res. 2022;72(2):e12782. https:\/\/doi.org\/10.1111\/jpi.12782.","journal-title":"J Pineal Res"},{"issue":"9","key":"1369_CR82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","volume":"19","author":"A Wichniak","year":"2017","unstructured":"Wichniak A, Wierzbicka A, Walecka M, Jernajczyk W. Effects of antidepressants on sleep. Curr Psychiatry Rep. 2017;19(9):63. https:\/\/doi.org\/10.1007\/s11920-017-0816-4.","journal-title":"Curr Psychiatry Rep"},{"key":"1369_CR83","doi-asserted-by":"publisher","first-page":"110162","DOI":"10.1016\/j.pnpbp.2020.110162","volume":"108","author":"E Moon","year":"2021","unstructured":"Moon E, Lavin P, Storch KF, Linnaranta O. Effects of antipsychotics on circadian rhythms in humans: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;108:110162. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110162.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1369_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-022-01278-5","author":"E Moon","year":"2022","unstructured":"\u2022\u2022 Moon E, Partonen T, Beaulieu S, Linnaranta O. Melatonergic agents influence the sleep-wake and circadian rhythms in healthy and psychiatric participants: a systematic review and meta-analysis of randomized controlled trials. Neuropsychopharmacology. 2022. https:\/\/doi.org\/10.1038\/s41386-022-01278-5. This systematic review and meta-analysis reported the good evidence of melatonin usage in healthy individual and psychiatric patients according to dosage and dosing timing.","journal-title":"Neuropsychopharmacology"},{"key":"1369_CR85","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Geoffroy PA, Micoulaud Franchi JA, Lopez R, Schroder CM. Membres du consensus Melatonine S. The use of melatonin in adult psychiatric disorders: expert recommendations by the French institute of medical research on sleep (SFRMS). Encephale. 2019;45(5):413\u201323. https:\/\/doi.org\/10.1016\/j.encep.2019.04.068. This recent review paper recommended the clinical usage of melatonin in psychiatric disorders. These expert recommendations could be optimal guideline when prescribing melatonin for correcting sleep and circadian rhythms in psychiatric disorders.","DOI":"10.1016\/j.encep.2019.04.068"},{"issue":"5","key":"1369_CR86","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/0748730403256796","volume":"18","author":"LM Hack","year":"2003","unstructured":"Hack LM, Lockley SW, Arendt J, Skene DJ. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms. 2003;18(5):420\u20139. https:\/\/doi.org\/10.1177\/0748730403256796.","journal-title":"J Biol Rhythms"},{"issue":"1\u20132","key":"1369_CR87","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/s0006-8993(01)02964-x","volume":"918","author":"AJ Lewy","year":"2001","unstructured":"Lewy AJ, Bauer VK, Hasler BP, Kendall AR, Pires ML, Sack RL. Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res. 2001;918(1\u20132):96\u2013100. https:\/\/doi.org\/10.1016\/s0006-8993(01)02964-x.","journal-title":"Brain Res"},{"issue":"2","key":"1369_CR88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jsmc.2009.02.006","volume":"4","author":"CI Eastman","year":"2009","unstructured":"Eastman CI, Burgess HJ. How to travel the world without jet lag. Sleep Med Clin. 2009;4(2):241\u201355. https:\/\/doi.org\/10.1016\/j.jsmc.2009.02.006.","journal-title":"Sleep Med Clin"},{"issue":"7","key":"1369_CR89","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1210\/jc.2009-2590","volume":"95","author":"HJ Burgess","year":"2010","unstructured":"Burgess HJ, Revell VL, Molina TA, Eastman CI. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab. 2010;95(7):3325\u201331. https:\/\/doi.org\/10.1210\/jc.2009-2590.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1369_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11920-021-01291-3","volume":"23","author":"E Moon","year":"2021","unstructured":"Moon E, Yang M, Seon Q, Linnaranta O. Relevance of objective measures in psychiatric disorders-rest-activity rhythm and psychophysiological measures. Curr Psychiatry Rep. 2021;23(12):85. https:\/\/doi.org\/10.1007\/s11920-021-01291-3.","journal-title":"Curr Psychiatry Rep"},{"issue":"9","key":"1369_CR91","doi-asserted-by":"publisher","first-page":"131","DOI":"10.17116\/jnevro2021121091131","volume":"121","author":"SS Potanin","year":"2021","unstructured":"Potanin SS, Morozova MA. Oxidative stress in schizophrenia as a promising target for psychopharmacotherapy. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(9):131\u20138. https:\/\/doi.org\/10.17116\/jnevro2021121091131.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"14","key":"1369_CR92","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1017\/S0033291719001995","volume":"49","author":"N Cakici","year":"2019","unstructured":"Cakici N, van Beveren NJM, Judge-Hundal G, Koola MM, Sommer IEC. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis. Psychol Med. 2019;49(14):2307\u201319. https:\/\/doi.org\/10.1017\/S0033291719001995.","journal-title":"Psychol Med"},{"issue":"10","key":"1369_CR93","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1097\/00001756-199807130-00043","volume":"9","author":"YS Kim","year":"1998","unstructured":"Kim YS, Joo WS, Jin BK, Cho YH, Baik HH, Park CW. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system. NeuroReport. 1998;9(10):2387\u201390. https:\/\/doi.org\/10.1097\/00001756-199807130-00043.","journal-title":"NeuroReport"},{"issue":"3","key":"1369_CR94","doi-asserted-by":"publisher","first-page":"129","DOI":"10.11919\/j.issn.1002-0829.217046","volume":"29","author":"CH Sun","year":"2017","unstructured":"Sun CH, Zheng W, Yang XH, Cai DB, Ng CH, Ungvari GS, et al. adjunctive melatonin for tardive dyskinesia in patients with schizophrenia: a meta-analysis. Shanghai Arch Psychiatry. 2017;29(3):129\u201336. https:\/\/doi.org\/10.11919\/j.issn.1002-0829.217046.","journal-title":"Shanghai Arch Psychiatry"},{"issue":"1","key":"1369_CR95","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41398-021-01464-x","volume":"11","author":"LM Melhuish Beaupre","year":"2021","unstructured":"Melhuish Beaupre LM, Brown GM, Goncalves VF, Kennedy JL. Melatonin\u2019s neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders. Transl Psychiatry. 2021;11(1):339. https:\/\/doi.org\/10.1038\/s41398-021-01464-x.","journal-title":"Transl Psychiatry"},{"issue":"4","key":"1369_CR96","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41419-019-1556-7","volume":"10","author":"A Tarocco","year":"2019","unstructured":"Tarocco A, Caroccia N, Morciano G, Wieckowski MR, Ancora G, Garani G, et al. Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis. 2019;10(4):317. https:\/\/doi.org\/10.1038\/s41419-019-1556-7.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1369_CR97","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cei.13334","volume":"197","author":"FC Bennett","year":"2019","unstructured":"Bennett FC, Molofsky AV. The immune system and psychiatric disease: a basic science perspective. Clin Exp Immunol. 2019;197(3):294\u2013307. https:\/\/doi.org\/10.1111\/cei.13334.","journal-title":"Clin Exp Immunol"},{"key":"1369_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010305","author":"E Won","year":"2021","unstructured":"Won E, Na KS, Kim YK. Associations between melatonin, neuroinflammation, and brain alterations in depression. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms23010305.","journal-title":"Int J Mol Sci"},{"key":"1369_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2821","author":"A Miola","year":"2021","unstructured":"Miola A, Fornaro M, Sambataro F, Solmi M. Melatonin and melatonin-agonists for metabolic syndrome components in patients treated with antipsychotics: a systematic review and meta-analysis. Hum Psychopharmacol. 2021. https:\/\/doi.org\/10.1002\/hup.2821.","journal-title":"Hum Psychopharmacol"},{"issue":"7","key":"1369_CR100","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3109\/15622975.2015.1048725","volume":"17","author":"L Baandrup","year":"2016","unstructured":"Baandrup L, Lindschou J, Winkel P, Gluud C, Glenthoj BY. Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: a randomised, placebo-controlled, blinded trial. World J Biol Psychiatry. 2016;17(7):514\u201324. https:\/\/doi.org\/10.3109\/15622975.2015.1048725.","journal-title":"World J Biol Psychiatry"},{"key":"1369_CR101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.psychres.2016.04.031","volume":"240","author":"L Baandrup","year":"2016","unstructured":"Baandrup L, Glenthoj BY, Jennum PJ. Objective and subjective sleep quality: melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use. Psychiatry Res. 2016;240:163\u20139. https:\/\/doi.org\/10.1016\/j.psychres.2016.04.031.","journal-title":"Psychiatry Res"},{"key":"1369_CR102","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jad.2018.11.064","volume":"245","author":"BL Parry","year":"2019","unstructured":"Parry BL, Meliska CJ, Lopez AM, Sorenson DL, Martinez LF, Orff HJ, et al. Early versus late wake therapy improves mood more in antepartum versus postpartum depression by differentially altering melatonin-sleep timing disturbances. J Affect Disord. 2019;245:608\u201316. https:\/\/doi.org\/10.1016\/j.jad.2018.11.064.","journal-title":"J Affect Disord"},{"issue":"9","key":"1369_CR103","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/abm\/kaaa012","volume":"54","author":"O Linnaranta","year":"2020","unstructured":"Linnaranta O, Bourguignon C, Crescenzi O, Sibthorpe D, Buyukkurt A, Steiger H, et al. Late and instable sleep phasing is associated with irregular eating patterns in eating disorders. Ann Behav Med. 2020;54(9):680\u201390. https:\/\/doi.org\/10.1093\/abm\/kaaa012.","journal-title":"Ann Behav Med"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-022-01369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-022-01369-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-022-01369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T05:26:38Z","timestamp":1667453198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-022-01369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1007\/s11920-022-01369-6","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"22 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eunsoo Moon, Kyungwon Kim, Timo Partonen, and Outi Linnaranta declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}